Published in Bioorg Med Chem Lett on December 20, 2004
Structural probing of the HIV-1 polypurine tract RNA:DNA hybrid using classic nucleic acid ligands. Nucleic Acids Res (2008) 0.94
Inhibitory effects of archetypical nucleic acid ligands on the interactions of HIV-1 nucleocapsid protein with elements of Psi-RNA. Nucleic Acids Res (2006) 0.93
1,3-Diazepanes of natural product-like complexity from cyanamide-induced rearrangement of epoxy-delta-lactams. Org Lett (2010) 0.82
The RNA Modification Database, RNAMDB: 2011 update. Nucleic Acids Res (2010) 3.42
NCCN Biosimilars White Paper: regulatory, scientific, and patient safety perspectives. J Natl Compr Canc Netw (2011) 2.73
Characterization of amino acid side chain losses in electron capture dissociation. J Am Soc Mass Spectrom (2002) 1.56
Complex interactions of HIV-1 nucleocapsid protein with oligonucleotides. Nucleic Acids Res (2006) 1.47
Assembly PCR oligo maker: a tool for designing oligodeoxynucleotides for constructing long DNA molecules for RNA production. Nucleic Acids Res (2005) 1.35
Resistance to RevM10 inhibition reflects a conformational switch in the HIV-1 Rev response element. Proc Natl Acad Sci U S A (2008) 1.22
Conversions of formaldehyde-modified 2'-deoxyadenosine 5'-monophosphate in conditions modeling formalin-fixed tissue dehydration. J Histochem Cytochem (2005) 1.21
Electron capture dissociation and infrared multiphoton dissociation of oligodeoxynucleotide dications. J Am Soc Mass Spectrom (2003) 1.18
Direct mass spectrometric determination of the stoichiometry and binding affinity of the complexes between nucleocapsid protein and RNA stem-loop hairpins of the HIV-1 Psi-recognition element. Biochemistry (2003) 1.15
Top-down characterization of nucleic acids modified by structural probes using high-resolution tandem mass spectrometry and automated data interpretation. Anal Chem (2004) 1.10
MS3D structural elucidation of the HIV-1 packaging signal. Proc Natl Acad Sci U S A (2008) 1.10
NCCN Task Force Report: Specialty Pharmacy. J Natl Compr Canc Netw (2010) 1.10
Prospective type 1 and type 2 disulfides of Keap1 protein. Chem Res Toxicol (2008) 1.09
Letter: the diagnostic value of amino acid side-chain losses in electron capture dissociation of polypeptides. Comment on: "Can the (M(.)-X) region in electron capture dissociation provide reliable information on amino acid composition of polypeptides?", Eur. J. Mass Spectrom. 8, 461-469 (2002). Eur J Mass Spectrom (Chichester, Eng) (2003) 1.08
Mechanism of host-guest complexation by cucurbituril. J Am Chem Soc (2004) 1.03
Untying the FIV frameshifting pseudoknot structure by MS3D. J Mol Biol (2005) 1.03
Dissecting the protein-RNA and RNA-RNA interactions in the nucleocapsid-mediated dimerization and isomerization of HIV-1 stemloop 1. J Mol Biol (2006) 1.03
Characterization of the genes encoding the cytosolic and plastidial forms of ADP-glucose pyrophosphorylase in wheat endosperm. Plant Physiol (2002) 1.02
Direct probing of RNA structures and RNA-protein interactions in the HIV-1 packaging signal by chemical modification and electrospray ionization fourier transform mass spectrometry. J Mol Biol (2003) 0.98
In vitro activity of novel dual action MDR anthranilamide modulators with inhibitory activity on CYP-450 (Part 2). Bioorg Med Chem (2007) 0.98
Understanding the isomerization of the HIV-1 dimerization initiation domain by the nucleocapsid protein. J Mol Biol (2007) 0.97
SHAMS: combining chemical modification of RNA with mass spectrometry to examine polypurine tract-containing RNA/DNA hybrids. RNA (2009) 0.95
Structural probing of the HIV-1 polypurine tract RNA:DNA hybrid using classic nucleic acid ligands. Nucleic Acids Res (2008) 0.94
Inhibitory effects of archetypical nucleic acid ligands on the interactions of HIV-1 nucleocapsid protein with elements of Psi-RNA. Nucleic Acids Res (2006) 0.93
The collaboratory for MS3D: a new cyberinfrastructure for the structural elucidation of biological macromolecules and their assemblies using mass spectrometry-based approaches. J Proteome Res (2008) 0.93
Toward building a database of bifunctional probes for the MS3D investigation of nucleic acids structures. J Am Soc Mass Spectrom (2006) 0.91
Mapping noncovalent ligand binding to stemloop domains of the HIV-1 packaging signal by tandem mass spectrometry. J Am Soc Mass Spectrom (2006) 0.91
Nested Arg-specific bifunctional crosslinkers for MS-based structural analysis of proteins and protein assemblies. Anal Chim Acta (2008) 0.89
Use and prescribing patterns for erythropoiesis-stimulating agents in inpatient and outpatient hospital settings. Am J Health Syst Pharm (2008) 0.88
Atmospheric pressure MALDI-FTMS of normal and chemically modified RNA. J Am Soc Mass Spectrom (2005) 0.87
Design, synthesis, and biological evaluation of 3,4-dihydroquinolin-2(1H)-one and 1,2,3,4-tetrahydroquinoline-based selective human neuronal nitric oxide synthase (nNOS) inhibitors. J Med Chem (2011) 0.86
Novel 2-aminobenzothiazoles as selective neuronal nitric oxide synthase inhibitors. Bioorg Med Chem Lett (2007) 0.86
The essential role of stacking adenines in a two-base-pair RNA kissing complex. J Am Chem Soc (2013) 0.86
Discovery of N-(3-(1-methyl-1,2,3,6-tetrahydropyridin-4-yl)-1H-indol-6-yl) thiophene-2-carboximidamide as a selective inhibitor of human neuronal nitric oxide synthase (nNOS) for the treatment of pain. J Med Chem (2011) 0.86
Clerocidin alkylates DNA through its epoxide function: evidence for a fine tuned mechanism of action. Nucleic Acids Res (2003) 0.86
Toward multiplexing the application of solvent accessibility probes for the investigation of RNA three-dimensional structures by electrospray ionization-Fourier transform mass spectrometry. Anal Biochem (2004) 0.86
Noncovalent probes for the investigation of structure and dynamics of protein-nucleic acid assemblies: the case of NC-mediated dimerization of genomic RNA in HIV-1. Biopolymers (2009) 0.86
1,5-Disubstituted indole derivatives as selective human neuronal nitric oxide synthase inhibitors. Bioorg Med Chem Lett (2011) 0.85
First-in-class, dual-action, 3,5-disubstituted indole derivatives having human nitric oxide synthase (nNOS) and norepinephrine reuptake inhibitory (NERI) activity for the treatment of neuropathic pain. J Med Chem (2012) 0.85
Label-free solution-based kinetic study of aptamer-small molecule interactions by kinetic capillary electrophoresis with UV detection revealing how kinetics control equilibrium. Anal Chem (2011) 0.84
End-stacking of copper cationic porphyrins on parallel-stranded guanine quadruplexes. J Biol Inorg Chem (2007) 0.84
3,5-Disubstituted indole derivatives as selective human neuronal nitric oxide synthase (nNOS) inhibitors. Bioorg Med Chem Lett (2012) 0.83
Like polarity ion/ion reactions enable the investigation of specific metal interactions in nucleic acids and their noncovalent assemblies. J Am Chem Soc (2008) 0.83
Primary and secondary structure dependence of peptide flexibility assessed by fluorescence-based measurement of end-to-end collision rates. J Am Chem Soc (2004) 0.83
Defining a stem length-dependent binding mechanism for the cocaine-binding aptamer. A combined NMR and calorimetry study. Biochemistry (2010) 0.83
A comparative molecular field analysis (CoMFA) and comparative molecular similarity indices analysis (CoMSIA) of anthranilamide derivatives that are multidrug resistance modulators. J Med Chem (2006) 0.82
1,6-Disubstituted indole derivatives as selective human neuronal nitric oxide synthase inhibitors. Bioorg Med Chem Lett (2011) 0.82
Concerted bis-alkylating reactivity of clerocidin towards unpaired cytosine residues in DNA. Nucleic Acids Res (2004) 0.82
The NMR and X-ray structures of the Saccharomyces cerevisiae Vts1 SAM domain define a surface for the recognition of RNA hairpins. J Mol Biol (2005) 0.82
Probing anomalous structural features in polypurine tract-containing RNA-DNA hybrids with neomycin B. Biochemistry (2009) 0.82
Alkylation of nucleic acids by the antitumor agent COMC. Org Lett (2002) 0.82
Quinine binding by the cocaine-binding aptamer. Thermodynamic and hydrodynamic analysis of high-affinity binding of an off-target ligand. Biochemistry (2013) 0.81
Rapid purification of RNA secondary structures. Nucleic Acids Res (2003) 0.81
Direct infusion analysis of nucleotide mixtures of very similar or identical elemental composition. J Mass Spectrom (2013) 0.81
Defining the secondary structural requirements of a cocaine-binding aptamer by a thermodynamic and mutation study. Biophys Chem (2010) 0.80
Novel, druglike 1,7-disubstituted 2,3,4,5-tetrahydro-1H-benzo[b]azepine-based selective inhibitors of human neuronal nitric oxide synthase (nNOS). Bioorg Med Chem Lett (2012) 0.80
Current issues in pharmaceutical reimbursement. Am J Health Syst Pharm (2008) 0.80
Effects of common buffer systems on drug activity: the case of clerocidin. Chem Res Toxicol (2004) 0.80
Engineering a structure switching mechanism into a steroid-binding aptamer and hydrodynamic analysis of the ligand binding mechanism. Biochemistry (2011) 0.80
Measuring the binding stoichiometry of HIV-1 Gag to very-low-density oligonucleotide surfaces using surface plasmon resonance spectroscopy. J Biomol Tech (2007) 0.79
Kinetic size-exclusion chromatography with mass spectrometry detection: an approach for solution-based label-free kinetic analysis of protein-small molecule interactions. Anal Chem (2014) 0.79
seco-C/D ring analogues of ergot alkaloids. Synthesis via intramolecular Heck and ring-closing metathesis reactions. Org Lett (2003) 0.79
Identification of binding specificity-determining features in protein families. J Med Chem (2012) 0.78
Mass spectrometric investigation of protein alkylation by the RNA footprinting probe kethoxal. J Mass Spectrom (2005) 0.78
Kinetic capillary electrophoresis with mass-spectrometry detection (KCE-MS) facilitates label-free solution-based kinetic analysis of protein-small molecule binding. Chembiochem (2011) 0.78
Electric susceptibility of unsolvated glycine-based peptides. J Am Chem Soc (2002) 0.78
Atmospheric pressure MALDI-fourier transform mass spectrometry. Anal Chem (2004) 0.77
In vitro activity of novel dual action MDR anthranilamide modulators with inhibitory activity at CYP-450. Bioorg Med Chem (2006) 0.77
Current-controlled nanospray ionization mass spectrometry. J Am Soc Mass Spectrom (2009) 0.77
cADPR analogues: effect of an adenosine 2'- or 3'-methoxy group on conformation. Org Lett (2004) 0.76
Continued challenges with the use of erythropoiesis-stimulating agents in patients with cancer: perspectives and issues on policy-guided health care. Pharmacotherapy (2008) 0.75
Finding the path in an RNA folding landscape. Structure (2010) 0.75
Erratum: Profiling ribonucleotide modifications at full-transcriptome level: a step toward MS-based epitranscriptomics. RNA (2015) 0.75
Direct probing of zwitterion formation in unsolvated peptides. J Am Chem Soc (2003) 0.75
Where are risk evaluation and mitigation strategies headed? Am J Health Syst Pharm (2010) 0.75
Quantitative affinity electrophoresis of RNA-small molecule interactions by cross-linking the ligand to acrylamide. Anal Biochem (2013) 0.75
Enhanced NMR signal detection of imino protons in RNA molecules containing 3' dangling nucleotides. J Biomol NMR (2008) 0.75
Thermodynamic and NMR analysis of inhibitor binding to dihydrofolate reductase. Bioorg Med Chem (2010) 0.75
Gas chromatography method for the characterization of ethanol steam reforming products. J Chromatogr Sci (2007) 0.75
An antibiotic linked to peptides and proteins is released by electron capture dissociation fourier transform ion cyclotron resonance mass spectrometry. J Am Soc Mass Spectrom (2003) 0.75